Early loss of dopamlinergic terminals in striosomes after MDMA administration to mice

被引:58
作者
Granado, Noelia
Escobedo, Isabel
O'Shea, Esther
Colado, M. Isabel
Moratalla, Rosario
机构
[1] CSIC, Inst Cajal, E-28002 Madrid, Spain
[2] Inst Salud Carlos III, CIBERNED, Madrid, Spain
[3] Univ Complutense, Fac Med, Dept Pharmacol, E-28040 Madrid, Spain
关键词
TH; ecstasy; striatum; neurotoxicity; dopamine; addiction;
D O I
10.1002/syn.20466
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The amphetamine analogue 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") is a popular drug of abuse which causes different neurotoxic effects in the mouse compared with the rat. In mice, MDMA produces damage to striatal dopamine terminals, having little long-term effects on serotonin (5-HT) containing neurons. A relevant feature of the striatum is its striosome/matrix compartmental organization; defined by different connexions, and functions. In this study we examined the long-term effect induced by MDMA on tyrosine hydroxylase (TH) and dopamine transporter (DAT) immunoreactivity in the striosomes and matrix compartments of mouse striatum. Mice given MDMA showed significant reductions in TH and DAT immunostaining in striatum compared with control animals. Interestingly, this effect was considerably more pronounced in striosomes than in the matrix. These data provide the first evidence that striosomes and matrix compartments of the mouse striatum have differential vulnerability to MDMA and that the long-term neurotoxicity induced by MDMA in mice is primarily associated with a loss of striosomal dopamine fibres.
引用
收藏
页码:80 / 84
页数:5
相关论文
共 25 条
[1]  
ARVIDSSON U, 1995, J NEUROSCI, V15, P3328
[2]  
Berretta S, 1997, J NEUROSCI, V17, P4752
[3]   Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions [J].
Broening, HW ;
Morford, LL ;
Vorhees, CV .
SYNAPSE, 2005, 56 (02) :84-93
[4]   RELATIVE LOSS OF THE STRIATAL STRIOSOME COMPARTMENT, DEFINED BY CALBINDIN-D(28K) IMMUNOSTAINING, FOLLOWING DEVELOPMENTAL HYPOXIC-ISCHEMIC I NJURY [J].
BURKE, RE ;
BAIMBRIDGE, KG .
NEUROSCIENCE, 1993, 56 (02) :305-315
[5]   SUPEROXIDE RADICALS MEDIATE THE BIOCHEMICAL EFFECTS OF METHYLENEDIOXYMETHAMPHETAMINE (MDMA) - EVIDENCE FROM USING CUZN-SUPEROXIDE DISMUTASE TRANSGENIC MICE [J].
CADET, JL ;
LADENHEIM, B ;
HIRATA, H ;
ROTHMAN, RB ;
ALI, S ;
CARLSON, E ;
EPSTEIN, C ;
MORAN, TH .
SYNAPSE, 1995, 21 (02) :169-176
[6]   Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum [J].
Camarero, J ;
Sanchez, V ;
O'Shea, E ;
Green, AR ;
Colado, MI .
JOURNAL OF NEUROCHEMISTRY, 2002, 81 (05) :961-972
[7]   Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types [J].
Figueredo-Cardenas, G ;
Harris, CL ;
Anderson, KD ;
Reiner, A .
EXPERIMENTAL NEUROLOGY, 1998, 149 (02) :356-372
[8]   Mitochondria in neurodegeneration: Acute ischemia and chronic neurodegenerative diseases [J].
Fiskum, G ;
Murphy, AN ;
Beal, MF .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (04) :351-369
[9]   DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy) [J].
Fornai, F ;
Lenzi, P ;
Frenzilli, G ;
Gesi, M ;
Ferrucci, M ;
Lazzeri, G ;
Biagioni, F ;
Nigro, M ;
Falleni, A ;
Giusiani, M ;
Pellegrini, A ;
Blandini, F ;
Ruggieri, S ;
Paparelli, A .
PSYCHOPHARMACOLOGY, 2004, 173 (3-4) :353-363
[10]  
GRANADO N, 2007, D1 NOT D5 DOPAMINE R